Pathological and epidemiological studies on the pathogenesis of B-cell lymphoma
B细胞淋巴瘤发病机制的病理学和流行病学研究
基本信息
- 批准号:01015065
- 负责人:
- 金额:$ 1.34万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Cancer Research
- 财政年份:1989
- 资助国家:日本
- 起止时间:1989 至 1990
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The purpose of this study is to show an etiologically important role of long-standing inflammation for development of B-cell lymphoma. The main results of my study obtained during the period April 1989 to January 1990 are as follows: 1. Thyroid lymphoma (1) Chromosome analysis suggested that thyroid lymphoma could be divided into two groups: the first group showed numerical abnormalities with clinical features of relatively slow growing struma and presence of anti-thyroid antibodies in the serum. The second group showed structural abnormalities such as 14q+ with rapidly growing struma and low positive rate of antithyroid antibodies. (2) Thyroid lymphomas in ATL non-endemic area were exclusively of B-cell type, but integration of EB virus genomes in the tumor cells were exceptional in these tumors. We are now making pathological and immunological studies on the patients with Hashimoto's disease and thyroid lymphoma in the ATL endemic area. 2. Pleural lymphoma developing in the patients with chronic tuberculous pyothorax I had previously suggested an etiologically important role of chronic tuberculous pyothorax for development of pleural lymphoma. In 1989, we have carried out nation-wide study of pleural lymphoma in Japan, and the results were (1) the age of patients ranged from 46-81 years(mean 63 years) with a male to female ratio of 5.2:1, (2) all patients had over 20 years history of Chronic tuberculous pyothorax, (3) tumor cells were exclusively of B-cell type.From the findings shown by us and other investigators it is suggested that B-cell lymphoma could evolve in the tissue affected by chronic inflammation of autoimmune or non-autoimmune nature. I am now preparing case-control study to investigate risk factor for development of pleural lymphomas among the patients with tuberculous pyothoiax.
本研究的目的是显示长期炎症对B细胞淋巴瘤发展的重要病因作用。本研究于1989年4月至1990年1月进行,主要结果如下:1.甲状腺淋巴瘤(1)染色体分析提示,甲状腺淋巴瘤可分为两组:第一组染色体数目异常,临床表现为甲状腺肿生长相对缓慢,血清中有抗甲状腺抗体。第二组表现为结构异常,如14 q+,甲状腺肿迅速增长,抗甲状腺抗体阳性率低。(2)ATL非流行区的甲状腺淋巴瘤均为B细胞型,但EB病毒基因组在肿瘤细胞中的整合在这些肿瘤中是例外。我们正在对ATL流行区的桥本病和甲状腺淋巴瘤患者进行病理学和免疫学研究。2.胸膜淋巴瘤发生于慢性结核性脓胸患者,我以前曾提出慢性结核性脓胸在胸膜淋巴瘤的发生中具有重要的病因作用。1989年,我们在日本全国范围内对胸膜淋巴瘤进行了研究,结果表明:(1)患者年龄46-81岁(平均63岁),男女之比为5.2:1;(2)所有患者均有20年以上的慢性结核性脓胸病史;(3)肿瘤细胞均为B细胞型。我正在准备一项病例对照研究,以探讨结核性脓胸患者发生胸膜淋巴瘤的危险因素。
项目成果
期刊论文数量(28)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Aozasa,K: "The nation-wide study of lethal midline granuloma in Japan:Ferquencies of Wegener's granulomatosis,polymorphic reticulosis,malignant lymphomas and others." Int J Cancer. 44. 63-66 (1989)
Aozasa,K:“日本致命性中线肉芽肿的全国性研究:韦格纳肉芽肿、多形性网状细胞增多症、恶性淋巴瘤等的频率。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ueda T, Aozasa K, et al.: "Malignant lymphoma of bone in Japan." Cancer 64: 2387-2392, 1989.
Ueda T、Aozasa K 等人:“日本的骨恶性淋巴瘤”。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Aozasa K, et al.: "Angioimmunoblastic lymphadenopathy-review of forty-four patients with emphasis on prognostic behavior." Cancer 63: 1625-1629, 1989.
Aozasa K 等人:“血管免疫母细胞性淋巴结病 - 对 44 名患者的回顾,重点是预后行为。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Suematsu S, Aozasa K, et al.: "IgGl plasmacytosis in interleukin 6 transgenic mice." Proc Natl Acad Sci(USA) 86: 7547-7551, 1989.
Suematsu S、Aozasa K 等人:“白细胞介素 6 转基因小鼠中的 IgG1 浆细胞增多症”。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Aozasa K, et al.: "Malignant lymphoma of thyroid." Leukemia and Lymphoma(in press).
Aozasa K 等人:“甲状腺恶性淋巴瘤。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
AOZASA Katsuyuki其他文献
AOZASA Katsuyuki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('AOZASA Katsuyuki', 18)}}的其他基金
Study on patho-epidemiology of malignant lymphoma in Japan
日本恶性淋巴瘤病理流行病学研究
- 批准号:
16390105 - 财政年份:2004
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Patho-epidemiological study on the nasal NK/T cell lymphoma.
鼻腔NK/T细胞淋巴瘤的病理流行病学研究。
- 批准号:
15406013 - 财政年份:2003
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis of DNA sequence of immunoglobulin heavy chain variable region gene in lymphomas developing from chronic inflammation
慢性炎症淋巴瘤免疫球蛋白重链可变区基因DNA序列分析
- 批准号:
12670159 - 财政年份:2000
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pathological and epidemiologic study on nasal NK/T-cell lymphoma
鼻腔NK/T细胞淋巴瘤的病理和流行病学研究
- 批准号:
12576004 - 财政年份:2000
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Study on modifying factors in the development of EBV-associated lymphomas
EBV相关淋巴瘤发生发展的调节因素研究
- 批准号:
09670184 - 财政年份:1997
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pathological study on nasal T-cell lymphoma in East Asia
东亚鼻T细胞淋巴瘤的病理学研究
- 批准号:
07042005 - 财政年份:1995
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for international Scientific Research
相似海外基金
RNA helicases; switched paralogue dependency as an exploitable vulnerability in aggressive B cell lymphoma.
RNA解旋酶;
- 批准号:
EP/Y030303/1 - 财政年份:2024
- 资助金额:
$ 1.34万 - 项目类别:
Research Grant
Chromatin-binding deubiquitinase MYSM1 as a putative drug target for cMYC-driven B cell lymphoma
染色质结合去泛素酶 MYSM1 作为 cMYC 驱动的 B 细胞淋巴瘤的推定药物靶点
- 批准号:
478278 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Operating Grants
From pathogenesis to new therapeutic targets in diffuse large B cell lymphoma
弥漫性大B细胞淋巴瘤从发病机制到新的治疗靶点
- 批准号:
10737214 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Diversity in BCL2-associated B-cell lymphoma
BCL2 相关 B 细胞淋巴瘤的多样性
- 批准号:
23H02697 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Integrative approach to identify genomic features that shape the immune landscape and predict immunotherapy response in diffuse large B cell lymphoma
识别塑造免疫景观并预测弥漫性大 B 细胞淋巴瘤免疫治疗反应的基因组特征的综合方法
- 批准号:
10660739 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
CRISPR screening of B-cell lymphoma to enhance CAR-T therapy
CRISPR 筛选 B 细胞淋巴瘤以增强 CAR-T 疗法
- 批准号:
23K15323 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
All roads lead to Rome: Tracing the evolutionary paths to diffuse large B-cell lymphoma
条条大路通罗马:追踪弥漫性大 B 细胞淋巴瘤的进化路径
- 批准号:
460772 - 财政年份:2022
- 资助金额:
$ 1.34万 - 项目类别:
Operating Grants
A Multi-disciplinary Approach to Investigating Canine Diffuse Large B cell Lymphoma
研究犬弥漫性大 B 细胞淋巴瘤的多学科方法
- 批准号:
2726000 - 财政年份:2022
- 资助金额:
$ 1.34万 - 项目类别:
Studentship
Identifying dysfunctional T-cell signatures in patients with aggressive diffuse large B cell lymphoma (DLBCL).
识别侵袭性弥漫性大 B 细胞淋巴瘤 (DLBCL) 患者功能失调的 T 细胞特征。
- 批准号:
2738591 - 财政年份:2022
- 资助金额:
$ 1.34万 - 项目类别:
Studentship
Role of FBXO45 in Diffuse Large B Cell Lymphoma Pathogenesis
FBXO45 在弥漫性大 B 细胞淋巴瘤发病机制中的作用
- 批准号:
10655478 - 财政年份:2022
- 资助金额:
$ 1.34万 - 项目类别: